发明公开
- 专利标题： PIPERIDINE COMPOUNDS AS ANTI-ALLERGIC
- 专利标题（中）： 哌啶使用AS抗过敏药
-
申请号： EP01983968.7申请日： 2001-10-15
-
公开(公告)号： EP1326858A2公开(公告)日： 2003-07-16
- 发明人: ASLANIAN, Robert, G. , SHIH, Neng-Yang , TING, Pauline, C. , BERLIN, Michael, Y. , ROSENBLUM, Stuart, B. , MC CORMICK, Kevin, D. , TOM, Wing, C. , BOYCE, Christopher, W. , MANGIARACINA, Pietro , MUTAHI, Mwangi, Wa , PIWINSKI, John, J.
- 申请人： Schering Corporation
- 申请人地址： Patent Department - K-6-1 1990,2000 Galloping Hill Road Kenilworth, NJ 07033-0530 US
- 专利权人： Schering Corporation
- 当前专利权人： Schering Corporation
- 当前专利权人地址： Patent Department - K-6-1 1990,2000 Galloping Hill Road Kenilworth, NJ 07033-0530 US
- 代理机构： Ritter, Stephen David
- 优先权： US240901P 20001017
- 国际公布： WO02032893 20020425
- 主分类号： C07D401/14
- IPC分类号： C07D401/14 ; C07D413/14 ; C07D401/12 ; C07D409/14 ; C07D498/04 ; C07D417/14
摘要：
Disclosed are novel compounds of the formula: (I) Also disclosed are pharmaceutical compositions comprising the compounds of Formula (I). Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula (I). Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula (I) in combination with a H1 receptor antagonist.
公开/授权文献
- EP1326858B1 PIPERIDINE COMPOUNDS AS ANTI-ALLERGIC 公开/授权日：2005-12-14
信息查询
